Form 4 for ISRG Intuitive Surgical
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-07 · accession 0001035267-24-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-08 | 2024-02-07 | ISRG | Rosa David J. | Pres | M - OptEx | $52.37 | +140.8K | 230.1K | +158% | +$7.38M |
| DM | 2024-02-08 | 2024-02-07 | ISRG | Rosa David J. | Pres | S - Sale+OE | $389.28 | -80.7K | 202.0K | -29% | -$31.42M |
| DM | 2024-02-08 | 2024-02-07 | ISRG | Rosa David J. | Pres | M - OptEx | $0.00 | -140.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-07 | M | A | 22,050 | $59.23 | 176,299 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-07 | S | D | 12,900 | $389.29 | 163,399 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,000 shares sold at $386.61 to $387.54; 2,050 shares sold at $387.70 to $388.67; 6,109 shares sold at $388.80 to $389.76; 3,201 shares sold at $389.84 to $390.61; and 540 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-02-07 | M | A | 22,050 | $57.11 | 185,449 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-07 | S | D | 12,840 | $389.30 | 172,609 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,100 shares sold at $386.61 to $387.54; 1,900 shares sold at $387.70 to $388.67; 5,974 shares sold at $388.80 to $389.75; 3,526 shares sold at $389.84 to $390.79; and 340 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-02-07 | M | A | 28,125 | $51.02 | 200,734 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-07 | S | D | 16,150 | $389.23 | 184,584 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,712 shares sold at $386.61 to $387.37; 2,350 shares sold at $387.70 to $388.42; 7,354 shares sold at $388.80 to $389.77; 4,094 shares sold at $389.84 to $390.73; and 640 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2024-02-07 | M | A | 40,500 | $49.09 | 225,084 | D | — | — | |
| 8 | Common | Common Stock | 2024-02-07 | M | A | 28,125 | $49.34 | 230,089 | D | — | — | |
| 9 | Common | Common Stock | 2024-02-07 | S | D | 15,700 | $389.29 | 214,389 | D | — | — | (F6) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57as follows: 1,300 shares sold at $386.61 to $387.54; 2,400 shares sold at $387.70 to $388.67; 7,622 shares sold at $388.77 to $389.75; 3,938 shares sold at $389.84 to $390.79; and 440 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2024-02-07 | S | D | 23,120 | $389.28 | 201,964 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $392.00 as follows: 2,057 shares sold at $386.61 to $387.37; 3,377 shares sold at $387.70 to $388.69; 10,942 shares sold at $388.77 to $389.77; 5,904 shares sold at $389.79 to $390.79; 740 shares sold at $390.91 to $391.57; and 100 shares sold at $392.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-07 | M | D | 40,500 | $0.00 | 0 | D | $49.09 · — to 2024-08-07 | 40,500 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-07 | M | D | 22,050 | $0.00 | 0 | D | $59.23 · — to 2025-08-17 | 22,050 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-07 | M | D | 22,050 | $0.00 | 0 | D | $57.11 · — to 2025-02-17 | 22,050 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-07 | M | D | 28,125 | $0.00 | 0 | D | $51.02 · — to 2024-08-15 | 28,125 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-07 | M | D | 28,125 | $0.00 | 0 | D | $49.34 · — to 2024-02-18 | 28,125 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |